Anti-human T Lymphocyte Porcine Immunoglobulin (Wuhan Zhongsheng Yujin)

抗人T细胞猪免疫球蛋白 (武汉中生毓晋)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-human T Lymphocyte Porcine Immunoglobulin (Wuhan Zhongsheng Yujin)
Drug Alias NameN/A
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsRejection of organ transplantation
Approved Indications in ChinaRejection of organ transplantation
Original Approved Country/TerritoryMainland China
Original Approved Date1983/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWuhan Zhongsheng Yujin Biomedical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Zhongsheng Yujin Biomedical Co Ltd
Inactive CompaniesN/A
Active IndicationsRejection of organ transplantation
Inactive IndicationsN/A

Other Information

ATC CodeL04AA
Related LinksN/A